Triplet Induction + 1 or 2-Drug Maintenance

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Near Add Your Location

Sorting 281 by

Alaska Women's Cancer Care
Anchorage, AK
  • Accepting patients
Anchorage Oncology Centre
Anchorage, AK
  • Accepting patients
Katmai Oncology Group
Anchorage, AK
  • Accepting patients
Mercy Hospital Fort Smith
Fort Smith, AR
  • Accepting patients
1,079 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.